實驗室離心機市場 - 增長、趨勢和預測 (2023-2028)
市場調查報告書
商品編碼
1273379

實驗室離心機市場 - 增長、趨勢和預測 (2023-2028)

Laboratory Centrifuge Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,實驗室離心機市場預計將以 5.0% 的複合年增長率註冊。

COVID-19 的龐大患者群體和實驗室離心機的潛在短缺正在推動實驗室離心機市場的增長。 例如,2022 年 2 月 NCBI 的一篇論文報告稱,在 COVID-19 大流行期間,對離心機分離唾液成分以檢測冠狀病毒的需求顯著增加。 然而,在目前的情況下,預計實驗室離心機的需求相對於大流行開始可能會趨於穩定。 然而,隨著其他 SARS-CoV-2 毒株的出現,在所研究的市場期內,對離心機的需求可能會增加。

推動市場增長的因素是該病的高患病率、研發活動投資的增加以及技術進步。 離心主要用於診斷某些傳染病,例如 HIV。 離心增強了 HIV-1 感染母親所生兒童血漿中 HIV-1 p24 抗原的檢測。 全球報告的 HIV 病例數量不斷增加,預計將增加對離心機的需求。 例如,聯合國艾滋病規劃署在 2022 年報告稱,到 2021 年全球將有 3840 萬人感染艾滋病毒,其中 85% 的人將進行自我診斷。 由於離心機還用於分離生物體液中的病原體和寄生蟲,因此 HIV 的高流行率可能會增加對用於樣品診斷的離心機的需求,從而增加所研究市場的規模,預計將促進增長。

此外,增加對製藥和生物技術研發部門的投資也有助於所研究市場的增長。 例如,2022 年 5 月,國家衛生統計中心 (NCHS) 估計,2021 年全球將有 78.47 億美元用於生物技術研發,到 2022 年底將達到 81.42 億美元。我正在報告。 研發投入的增加帶動了新藥的開發,離心機用於生產氨基酸、苯甲酸、苯、硫、次氯酸鈣、六氯環己烷、胰島素、青黴素、澱粉等各種用於藥物開發的中間體。分離物體。 因此,生物技術領域投資的增加導致研發活動的增加,從而增加了對實驗室離心機的需求並推動了研究市場的增長。

近年來,實驗室離心機市場的一些主要參與者推出了集成了先進轉子和其他功能的離心機。 例如,2021 年 4 月,Eppendorf AG(德國)推出了多功能離心機 5910 Ri,它提供了增強和簡化離心分離的高級功能。 該離心機是流行的 Centrifuge 5910 R 的後繼產品,具有創新的觸摸屏界面、遠程監控以及可選連接到新的 VisioNize 數字實驗室套件,無需更換轉子、轉子桶或適配器。它具有獨特的通用轉子,接受 50mL 錐形管、板和 250mL 瓶。 因此,新推出的離心機採用了更好的技術並提供了更好的結果,從而促進了所研究市場的增長。

雖然該市場有望表現良好,但高昂的設備成本和較長的設備使用壽命可能會減緩市場發展。

實驗室離心機市場趨勢

預計在預測期內,按型號劃分的台式離心機細分市場將出現顯著增長。

台式離心機是專為在密封腔室中安全操作產品而設計的台式離心機。 它易於操作,並具有自動鎖定係統,可單手快速更換轉子,以實現應用的多功能性和最大吞吐量。 這些離心機的設計最大限度地減少了打開和關閉蓋子時的潛在夾點,電動蓋子閂鎖提供了額外的保護。 由於台式離心機的成本效益、易用性和色譜、沉澱、過濾等的多功能性,預計在預測期內台式離心機將顯著增長。

台式離心機的易用性和兼容性正在推動該領域的發展。 例如,國家醫學圖書館在 2021 年 7 月發表的一篇文章稱,台式離心機因其有限的空間和多功能性而成為實驗室使用的首選。。 該文章還報告說,設計特點、樣品體積小、處理速度快和 RCF 高,使這款離心機得到廣泛應用,有助於該細分市場的增長。

此外,新產品的推出也推動了這一細分市場的增長。 例如,2021年6月,Kubota Corporation(日本)推出了USD 500T台式離心機和S500FR落地式冷凍離心機。

實驗室離心機市場-IMG1

北美預計在預測期內將顯著增長。

由於疾病的增加以及診斷和治療意識的提高,預計北美在預測期內將出現顯著增長。 此外,由於主要市場參與者的存在,產品發布、合併、合作夥伴關係和收購進一步推動了該地區的市場增長。

北美國家報告的結核病高發病率增加了離心機在樣本診斷中的使用。 大量結核病患者正在推動該國的市場增長,因為最佳的結核病檢測通常包括痰液離心和肉湯培養。 例如,2022 年 11 月發表的一篇 NCBI 論文發現,2021 年努納武特地區(加拿大)將診斷出 77 例活躍的結核病病例,比前一年增加一倍多。

同樣,在 2022 年 5 月,墨西哥政府報告稱,在 2020 年至 2021 年期間,有超過 90,000 人被診斷出感染了 HIV。

此外,技術發展、合作夥伴關係、兼併、收購和新產品發布正在推動該地區該市場的增長。 例如,2021 年 6 月,Quest Diagnostics 完成了對 Mercy 的 Outreach Laboratory Services 業務的收購。 該交易旨在增加獲得創新、高質量、負擔得起的實驗室服務的機會,以在整個中西部提供簡化的患者護理。 收購完成後,Quest 將可以立即訪問堪薩斯州、阿肯色州、密蘇裡州和俄克拉荷馬州廣泛的醫療保健專業人員網絡。

實驗室離心機市場-IMG2

實驗室離心機行業概況

實驗室離心機市場是分散的,由幾家大型企業組成。 Andreas Hettich GmbH & Co. KG、Danaher Corporation(Beckman Coulter, Inc)、Eppendorf AG、Thermo Fisher Scientific Inc、HERMLE Labortechnik GmbH、KUBOTA Corporation、Sartorius AG、NuAire、Sigma Laborzentrifugen GmbH、Qiagen NV。

其他福利:

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查假設和市場定義
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 疾病流行率高
    • 增加研發投資
    • 技術進步
  • 市場製約因素
    • 設備成本高
    • 設備壽命長
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品類型
    • 設備
      • 微型離心機
      • 超速離心機
      • 多用途離心機
    • 配飾
      • 轉子
      • 離心桶
      • 離心瓶
      • 盤子
  • 按型號
    • 落地式離心機
    • 台式離心機
  • 按使用目的
    • 臨床離心機
    • 臨床前離心機
    • 通用離心機
  • 通過使用
    • 微生物學
    • 纖維素組學
    • 蛋白質組學
    • 診斷
    • 基因組學
  • 地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Andreas Hettich GmbH & Co. KG
    • Danaher Corporation(Beckman Coulter, Inc.)
    • Eppendorf AG
    • Thermo Fisher Scientific Inc.
    • HERMLE Labortechnik GmbH
    • KUBOTA Corporation
    • Sartorius AG
    • NuAire
    • Sigma Laborzentrifugen GmbH
    • Qiagen NV

第七章市場機會與未來趨勢

簡介目錄
Product Code: 68923

The laboratory centrifuge market is expected to register a CAGR of 5.0% over the forecast period.

The large patient pool of COVID-19, along with the possible shortage of laboratory centrifuges, has fuelled the growth of the laboratory centrifuges market. For instance, an article published by the NCBI in February 2022 reported that during the COVID-19 pandemic, the demand for centrifuges significantly increased to separate the components of saliva for coronavirus detection. However, in the current scenario, it is anticipated that the demand for laboratory centrifuges may stabilize compared to the beginning of the pandemic. Still, with the emergence of other SARS-CoV-2 strains, the demand for centrifuges may increase over the studied market period.

The factors driving the growth of the studied market are the high prevalence of diseases, increasing investment in R&D activity, and technological advancements. Centrifugation is mainly used in the diagnosis of certain infectious diseases like HIV. Centrifugation improves the detection of HIV-1 p24 antigen in plasma from children born to mothers infected with HIV-1. The rising cases of HIV reported globally are expected to increase the demand for centrifuges. For instance, in 2022, UNAIDS reported that globally, 38.4 million people were living with HIV in the year 2021 and 85% of these people get diagnosed themselves. Since the centrifuge is also employed in the separation of pathogens and parasites in biological fluids, so the high incidence of HIV may increase the demand for centrifuges for sample diagnosis and thus be expected to drive the growth of the studied market.

Moreover, the increasing investment in pharmaceutical and biotechnology R&D sectors is also contributing to the growth of the studied market. For instance, in May 2022, National Center for Health Statistics (NCHS) reported that globally USD 7,847 million were invested in biotechnology R&D in the year 2021 and is expected to reach USD 8,142 million by the end of 2022. The increase in R&D investment will lead to the development of new drugs, and the centrifuge machinery is suited for separating amino acids, benzoic acid, benzene, sulfur, calcium hypochloride, hexachlorocyclohexane, insulin, penicillin, starch, and various other intermediate products used in drug development. Thus, increasing investments in the biotechnology sector are leading to increasing R&D activity, which is increasing the demand for laboratory centrifuges, thereby driving the growth of the studied market.

In recent years, certain key players in the laboratory centrifuges market have launched centrifuges integrated with advanced rotors and other features. For instance, in April 2021, Eppendorf AG (Germany) launched its Multipurpose Centrifuge 5910 Ri, which offers advanced features to enhance and simplify centrifugation. This centrifuge is the successor to the popular Centrifuge 5910 R. It offers an innovative touchscreen interface, an optional connection to the new VisioNize Digital Lab Suite for remote monitoring, and the unique Universal rotor, which allows 50 mL conical tubes, plates, and 250 mL bottles without the need to change the rotor, rotor buckets, or adapters. Thus, the new centrifuge launches are incorporated with better technology, delivering better results and thereby driving the growth of the studied market.

While the market is expected to perform well, the high equipment cost and long equipment lifespans may slow down its development.

Laboratory Centrifuge Market Trends

Benchtop Centrifuges Segment By Model Type is Expected to Witness Significant Growth Over the Forecast Period.

Benchtop centrifuges are engineered with benchtops to operate the product safely in the closed chamber. These are simple to operate and are accommodated with the auto-lock system to quickly exchange rotors with one hand for application versatility and maximum throughput. The design of these centrifuge minimizes potential pinch points while opening and closing the lid, and a motorized lid latch provides extra protection. Benchtop centrifuge is expected to witness significant growth over the forecast period owing to its cost-effective, easy-to-use, and versatile nature for chromatography, sedimentation, and filtration of samples.

The ease and compatibility of benchtop centrifuges are driving the growth of this segment. For instance, an article published by the National Library of Medicine in July 2021 reported that benchtop centrifuges are preferred for laboratory purposes as they require limited space and are used in various applications. The article also reported the design, small samples, fast processing, and high RCF features make this centrifuge widely used and thus contribute to the growth of this segment.

Furthermore, new product launches are also fueling the growth of this segment. For instance, in June 2021, KUBOTA Corporation (Japan) launched the Benchtop Centrifuge USD 500T and Floor-Standing Refrigerated Centrifuge S500FR.

Laboratory Centrifuge Market - IMG1

North America is Expected to Witness a Significant Growth Over the Forecast Period.

North America is expected to witness significant growth over the forecast period owing to the increasing prevalence of diseases and rising awareness about diagnosis and treatment. Also, product launches, mergers, partnerships, and acquisitions due to the presence of the key market players further fuel the growth of this market in the region.

The high incidence of tuberculosis (TB) reported in North American countries is increasing the use of centrifuges for diagnosing the samples. Optimal tuberculosis testing usually involves sputum centrifugation followed by broth culture, and thus the high number of TB cases is driving the growth of the market in the country. For instance, an article published by the NCBI in November 2022 reported that there were 77 active cases of tuberculosis diagnosed in Nunavut (Canada) in 2021, more than twice as many as the year before.

Similarly, in May 2022, the Government of Mexico reported that more than 90 thousand people were diagnosed with HIV during 2020-2021.

Moreover, technological developments and partnerships, mergers, acquisitions, and new product launches are driving the growth of this market in the region. For instance, in June 2021, Quest Diagnostics completed the acquisition of Mercy's Outreach Laboratory Services business. The transaction aims to increase access to innovative, high-quality, and affordable laboratory services to provide reasonable patient care throughout the Midwest. Upon completing the acquisition, Quest will gain immediate access to a broader network of healthcare professionals in Kansas, Arkansas, Missouri, and Oklahoma.

Laboratory Centrifuge Market - IMG2

Laboratory Centrifuge Industry Overview

The laboratory centrifuge market is fragmented and consists of several major players. In terms of market share, some of the prominent market participants are Andreas Hettich GmbH & Co. KG, Danaher Corporation (Beckman Coulter, Inc.), Eppendorf AG, Thermo Fisher Scientific Inc., HERMLE Labortechnik GmbH, KUBOTA Corporation, Sartorius AG, NuAire, Sigma Laborzentrifugen GmbH, and Qiagen NV.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Prevalence of Diseases
    • 4.2.2 Increasing Investment in R&D Activity
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Equipment Cost
    • 4.3.2 Long Equipment Lifespans
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Equipment
      • 5.1.1.1 Microcentrifuges
      • 5.1.1.2 Ultracentrifuges
      • 5.1.1.3 Multipurpose Centrifuges
    • 5.1.2 Accessories
      • 5.1.2.1 Tubes
      • 5.1.2.2 Rotors
      • 5.1.2.3 Centrifuge Buckets
      • 5.1.2.4 Centrifuge Bottles
      • 5.1.2.5 Plates
  • 5.2 By Model Type
    • 5.2.1 Floor-Standing Centrifuges
    • 5.2.2 Benchtop Centrifuges
  • 5.3 By Intended Use
    • 5.3.1 Clinical Centrifuges
    • 5.3.2 Preclinical Centrifuges
    • 5.3.3 General Purpose Centrifuges
  • 5.4 By Application
    • 5.4.1 Microbiology
    • 5.4.2 Cellomics
    • 5.4.3 Proteomics
    • 5.4.4 Diagnostics
    • 5.4.5 Genomics
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Andreas Hettich GmbH & Co. KG
    • 6.1.2 Danaher Corporation (Beckman Coulter, Inc.)
    • 6.1.3 Eppendorf AG
    • 6.1.4 Thermo Fisher Scientific Inc.
    • 6.1.5 HERMLE Labortechnik GmbH
    • 6.1.6 KUBOTA Corporation
    • 6.1.7 Sartorius AG
    • 6.1.8 NuAire
    • 6.1.9 Sigma Laborzentrifugen GmbH
    • 6.1.10 Qiagen NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS